HIMS News

Faruqi & Faruqi, LLP Urges Hims & Hers Health, Inc. (HIMS) Investors to Seek Counsel Before the November 2, 2026 Lead Plaintiff Deadline in the Securities Class Action Ready to Announce with Confidence?

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Hims & Hers Health, Inc. (HIMS)

ROSEN, RECOGNIZED INVESTOR RIGHTS COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMS

ROSEN, TOP-RANKED INVESTOR RIGHTS COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMS

Hims & Hers Health (HIMS) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before November 2, 2026 Lead Plaintiff Deadline

HIMS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Hims & Hers Health, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Kaplan Fox Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors with Losses to Contact the Firm Before November 2, 2026

Digital Braille Displays Market to Grow from USD 46.90 Billion in 2025 to USD 80.10 Billion by 2035, at 5.5% CAGR – SNS Insider

HIMS SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Hims Investors of Securities Class Action Lawsuit Deadline on November 2, 2026 Ready to Announce with Confidence?